John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,269 shares at $142.18 ($181K) on 2016-02-05, disclosed to the SEC on 2016-02-08.
Seasonal sale ($181k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.75 | 433 | $61K | 33.9% |
| 2 | $142.18 | 436 | $62K | 34.2% |
| 3 | $144.39 | 400 | $58K | 31.9% |
| Total | $142.73 avg | 1,269 | $181K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |